Literature DB >> 31743305

Descriptive Epidemiology of Gradual Return to Work for Workers With a Work-Acquired Musculoskeletal Disorder in British Columbia, Canada.

Esther T Maas1, Mieke Koehoorn, Christopher B McLeod.   

Abstract

OBJECTIVE: This study investigates the injury, socio-demographic, workplace, and temporal characteristics related with gradual return to work (RTW) among workers with a work-acquired musculoskeletal disorder in British Columbia, Canada.
METHODS: Accepted workers' compensation lost-time claims were extracted between 2010 and 2015 (n = 141,490). A multivariable logistic regression model was used to analyze the determinants of Gradual RTW.
RESULTS: Within 1 year after injury, 41.0% of workers had at least 1 day of Gradual RTW. Serious injury severity, female sex, increasing age, wage, and firm size, longer sickness absence, and recent previous claims increased the proportion of workers being provided with Gradual RTW.
CONCLUSION: Consideration of injury, socio-demographic, workplace, and temporal variability in the provision of Gradual RTW can identify inequalities in the provision and increase effective use of Gradual RTW for workers with musculoskeletal disorders.

Entities:  

Mesh:

Year:  2020        PMID: 31743305     DOI: 10.1097/JOM.0000000000001768

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Impact of anxiety and depression disorders on sustained return to work after work-related musculoskeletal strain or sprain: a gender stratified cohort study.

Authors:  Andrea Marie Jones; Mieke Koehoorn; Ute Bültmann; Christopher B McLeod
Journal:  Scand J Work Environ Health       Date:  2021-03-21       Impact factor: 5.024

2.  The Current Practice of Gradual Return to Work in Germany: A Qualitative Study Protocol.

Authors:  Inga L Schulz; Ralf Stegmann; Uta Wegewitz; Matthias Bethge
Journal:  Int J Environ Res Public Health       Date:  2022-03-21       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.